跳至主要内容
临床试验/CTRI/2020/07/026420
CTRI/2020/07/026420尚未招募2 期

Clinical study of Taqashshur-al-jild (psoriasis) with Therapeutic evaluation of Unani drugs Aftimoon (Cuscuta reflexa) with Ma ul Jubn (whey) as Joshanda (Decoction) and Magh Tukhmi Kharpaza (seed of kernel of musk melon) along with Gule Baboona (Matriucccaria chamomillia) as Zimad (paste) in its Management

central counsal for research in unani medicine new delhi1 个研究点 分布在 1 个国家目标入组 52 人开始时间: 2020年9月7日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
52
试验地点
1
主要终点
relief in signs and symptoms of psoriasis

研究概览

简要总结

Taqashshur -e -jild (psoriasis) comes within the heading of papulosqumous dermatosis and is chronically recurring disease. This is a non infectious inflammatory, genetically predisposed autoimmune disorder characterized by well defined erythematous plaques bearing large adherent silvery scales. The disease affects 1% to 3% of world population and some authors have mentioned 1% to 11% . In India it varies from 0.84% to 5.6% in different studies. In classical Unani text books psoriasis has been named under the heading of Taqashshur-e- jild on the basis of humoural theory according to them, excessive amount of khilt-e- ghaleez(abnormal sauda) accumulates under the skin and hampers its nutrition and function, due to which skin becomes dry and dead and fall out in the form of scales.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Participant Blinded

入排标准

年龄范围
10.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Clinically Diagnosed Patients of Psoriasis.
  • Patients irrespective of gender.
  • Patients in the age group of 10-60 years.
  • Clinically stable patients.
  • Patients who have agreed to sign the informed consent form and follow up the protocol.

排除标准

  • Subjects below the age group of 10 and above the age of 60 years.
  • Patients suffering from from other concomitant disorders like Dermatophytes,Eczema ,Seborrhic Dermatitis,Pityriasis Rosea.
  • Patients with systemic diseases like diabetes,malignancy.
  • patients who refuse to give written consent for the study.
  • pregnant and lactating women.
  • any of them not covered under inclusion criteria.

结局指标

主要结局

relief in signs and symptoms of psoriasis

时间窗: 6-12 Weeks.

次要结局

  • not applicable(not applicable)

研究者

发起方
central counsal for research in unani medicine new delhi
申办方类型
Contract research organization

研究点 (1)

Loading locations...

相似试验